RQ20 is the new major research quality evaluation at Lund University, based on self-evaluations and will involve around 5 000 members of staff.

RQ20 is tasked with providing a picture of how competitive the research of Lund University is in an international context. Above all, the evaluation is to look to the future by identifying strengths, weaknesses and development potential in all of the University´s different research environments and to produce advisory documentation for the future.

The evaluation is based on connected research environments (Units of Assessment). These are defined as subjects, in some cases as departments or divisions, and in others as larger research groups or research themes.

35 large Panels will be defined at Lund university each containing 4-8 Units of Assessment with external evaluator linked to each Panel. The Faculty of Medicine is divided in 9 Panels and 52 Units of Assessment.

Panels and units of assessment at the Faculty of Medicine

Panel 1: Neuroscience

Units of Assessments:

• 1A: Neurobiology and cell therapy
• 1B: Neurophysiology and neuronanomedicine

• 1C: Basal ganglia disease models

• 1D: Neurodegeneration, epilepsy, experimental therapeutics

• 1E: Dementia research

• 1F: Neurology and clinical neurogenetics

Panel 2: Cancer, basic, tranlational

Units of Assessments:

• 2A: Clinical Genetics
• 2B: Hematology and transfusion medicine
• 2D: Translational Cancer Research I
• 2E: Translational Cancer Research II

Panel 3: Cancer, clinical

Units of Assessments:

• 3A: Cancer research - clinical, basic
• 3B: Cancer research - experimental
• 3C: Tumor pathology
• 3D: Cancer research - abdominal, urological

Panel 4: Regenerative medicine

Units of Assessments:

• 4A: Molecular Medicine and Gene Therapy
• 4B: Molecular Hematology

Panel 5: Blood and defense

Units of Assessments:

• 5A: Clinical/molecular infection medicine
• 5B: Immunology and virology EMV
• 5C: Transfusion and hemostasis
• 5D: Clinical and experimental autoimmunity
• 5E: Clinical chemistry
• 5F: HIV and clinical virology
• 5G: Clinical and experimental microbiology
• 5H: Protein chemistry

Panel 6: Metabolic and cardiovascular research

Units of Assessments:

• 6A: Diabetes and insulin action
• 6B: Cardiovascular research
• 6C: Diabetes and defect islet function
• 6D: Diabetes genetics and epidemiology
• 6E: Type 1 diabetes

Panel 7: Sustainable health

Units of Assessments:

• 7A: Occupational and Environmental Medicine
• 7B: Global Health
• 7C: Older People, Ageing and Health
• 7D: EpiHealth, Registers, Epidemiology
• 7E: Community Medicine
• 7F: Activity, participation, mental health
• 7G: Rehabilitation medicine, Physiotherapy, Sports science, Health promotion
• 7H: Emergency and high-technological environments

Panel 8: Tissue, cell and molecular biology and medical techniques

Units of Assessments:

• 8A: Airway biology
• 8B: Vascular physiology
• 8C: Pharmacology and Structure biology
• 8D: Cell and molecular biology

Panel 9: Highly specialized clinical research

Units of Assessments:

• 9A: Gastrointestinal research
• 9B: Heart- Lung Research
• 9C: Orthopedics and hand surgery
• 9D: Audiology, speech-language-pathology, phoniatrics, ENT
• 9E: Psychiatry, Medical ethics, Medical history
• 9F: Surgery
• 9G: Medical imaging, physiology and radiation physics
• 9H: Pediatrics and Gynecology & obstetrics
• 9I: Eye and ear-nose-throat research
• 9J: Dermatology and Venereology
• 9K: Medical Radiation Physics